SCHEMBL30830987

SCHEMBL30830987

CN1C[C@H](Nc2cnn(C)c(=O)c2Br)C[C@H](c2ccc(C(=O)N3CCN(c4ccc(F)c(C5CCC(=O)NC5=O)c4)CC3)cc2)C1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KAT2B Q92831 10/20 0.49
▸ BRD9 Q9H8M2 3/20 0.49
▸ BRD1 O95696 1/20 0.49
▸ ACHE P22303 1/20 0.49
▸ BRPF1 P55201 1/20 0.49
▸ BPTF Q12830 1/20 0.49
▸ KAT2A Q92830 1/20 0.49
▸ BRD7 Q9NPI1 1/20 0.49
▸ BAZ2B Q9UIF8 1/20 0.49
▸ BRPF3 Q9ULD4 1/20 0.49
▸ PLK4 O00444 1/20 0.34
▸ CRBN Q96SW2 4/20 0.32
▸ IKZF3 Q9UKT9 2/20 0.32
▸ NR3C1 P04150 1/20 0.32
▸ PGR P06401 1/20 0.32
▸ SLC6A4 P31645 1/20 0.32
▸ KCNH2 Q12809 1/20 0.32
▸ PDE3B Q13370 1/20 0.32
▸ PDE3A Q14432 1/20 0.32
▸ DDB1 Q16531 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30830854 0.96 KAT2B (0.46) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30830735 0.93 KAT2B (0.49) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30831016 0.91 KAT2B (0.46) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30830570 0.90 KAT2B (0.47) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30831132 0.89 KAT2B (0.47) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30830743 0.89 KAT2B (0.49) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30830693 0.89 KAT2B (0.46) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30830869 0.88 KAT2B (0.47) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30830819 0.88 KAT2B (0.47) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30830728 0.87 KAT2B (0.51) KAT2BBRD9BRD1ACHEBRPF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4581025-A1 PYRIDAZINON DERIVATIVES AS KAT2 DEGRADERS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS Auron Therapeutics, Inc. (US) 2025-07-09 — — EP disclosed
WO-2024050078-A1 PYRIDAZINON DERIVATIVES AS KAT2 DEGRADERS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS AURON THERAPEUTICS, INC. (US) 2024-03-07 — — WO disclosed
Send feedback